<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11437">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00574340</url>
  </required_header>
  <id_info>
    <org_study_id>HP-00044875-SCCOR-Q4</org_study_id>
    <secondary_id>RFAHL04016</secondary_id>
    <nct_id>NCT00574340</nct_id>
  </id_info>
  <brief_title>Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 4</brief_title>
  <official_title>SCCOR in Hemostatic and Thrombotic Diseases Project 5 - Metabolic Causes of Thrombosis in Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Maryland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Maryland</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypoglycemia (low blood glucose level) occurs frequently in intensively treated patients
      with diabetes. Although hypoglycemia was thought to occur almost exclusively in T1DM, with
      the advent of improved metabolic control in T2DM, the incidence of hypoglycemia is rising in
      these patients. Therefore in this application, we will test the novel hypothesis that prior
      hypoglycemia will result in (cardiovascular complications) during subsequent hypoglycemia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will test the hypothesis that 1) hypoglycemia causes a prothrombotic state and
      defective endothelial function and 2) episodes of repeated hypoglycemia will result in
      greater impairments of endothelial function and an increased prothrombotic tendency.
      Preliminary data in healthy men demonstrates that hypoglycemia can dramatically increase
      PAI-1 levels and the PAI-1 to tPA ratio, thereby creating a prothrombotic state. Whether
      this also occurs in type 2 DM patients is unknown. Furthermore, the effects of hypoglycemia
      on endothelial function in T2DM are also unknown.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2007</start_date>
  <completion_date type="Actual">April 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Percent Changes in Endothelial Function as Measured by Flow Mediated Dilation by 2D Doppler Ultrasound</measure>
    <time_frame>6 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>A measure of the baseline arterial dilation is compared to the post intervention measure of dilation of the brachial artery.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Glucose clamp</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Day 1 euglycemia, day 2 hypoglycemia</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hyperinsulinemic Hypoglycemic Clamp</intervention_name>
    <description>hyperinsulinemic glucose clamp separated by 8 weeks</description>
    <arm_group_label>Glucose clamp</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  16 (8 female/ 8 male) Type 2 diabetic patients age 18-60 yrs

          -  16 (8 female/ 8 male) Non-diabetic controls age and weight matched

          -  Body mass index &gt;20 kg/m2

          -  Normal results of routine blood test to screen for hepatic, renal, and hematological
             abnormalities

          -  Female volunteers of childbearing potential: negative HCG pregnancy test

          -  Volunteers over 40 years old: normal baseline cardiac stress test

          -  For those with type 2 diabetes: HBA1C &gt;5.5%

          -  For those with type 2 diabetes: diabetes &lt; 20 years

          -  For those with type 2 diabetes: C-peptide &gt;0.2 nmol (1.1-4.4 ng/ml). If c-peptide is
             abnormal or there is a clinical suspicion of type 1 diabetes, MODY, or LADA,
             Anti-Islet cell (negative) and Glutamic Acid Decarboxylase (GAD) antibody negative
             (0.0-1.5 U/ml) will be performed

        Exclusion Criteria

          -  Uncontrolled hypertension

          -  History of cerebrovascular incidents

          -  Pregnancy

          -  Subjects unable to give voluntary informed consent

          -  Subjects with a recent medical illness

          -  Subjects on anticoagulant drugs, anemic, or with known bleeding diseases

          -  Tobacco Use

        Physical Exam Exclusion Criteria

          -  Blood Pressure greater than 150/95

          -  Clinically significant Cardiac Abnormalities (e.g. Heart Failure, Arrhythmias,
             ischemic tachycardia, S-T segment deviations, ect.) from history or from cardiac
             stress testing

          -  Pneumonia

          -  Hepatic Failure/Jaundice

          -  Renal Failure

          -  Acute Cerebrovascular/ Neurological deficit

          -  Fever greater than 38.0 C

        Screening blood tests exclusions according to protocol
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen N. Davis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Maryland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Maryland, Baltimore</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <lastchanged_date>January 9, 2015</lastchanged_date>
  <firstreceived_date>December 13, 2007</firstreceived_date>
  <firstreceived_results_date>May 27, 2014</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Maryland</investigator_affiliation>
    <investigator_full_name>Stephen N. Davis</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Type 2 Diabetes</keyword>
  <keyword>Endothelial Function</keyword>
  <keyword>Fibrinolytic Balance</keyword>
  <keyword>Hypoglycemia</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypoglycemic Agents</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Glucose Clamp</title>
          <description>Day 1 euglycemia, day 2 hypoglycemia
Hyperinsulinemic Hypoglycemic Clamp: hyperinsulinemic glucose clamp separated by 8 weeks</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Glucose Clamp</title>
          <description>Day 1 euglycemia, day 2 hypoglycemia
Hyperinsulinemic Hypoglycemic Clamp: hyperinsulinemic glucose clamp separated by 8 weeks</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="28"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="35" spread="1"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="28"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="14"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="14"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Hispanic or Latino</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Not Hispanic or Latino</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="28"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Unknown or Not Reported</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United States</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="28"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percent Changes in Endothelial Function as Measured by Flow Mediated Dilation by 2D Doppler Ultrasound</title>
        <description>A measure of the baseline arterial dilation is compared to the post intervention measure of dilation of the brachial artery.</description>
        <time_frame>6 hours</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Glucose Clamp</title>
            <description>Day 1 euglycemia, day 2 hypoglycemia
Hyperinsulinemic Hypoglycemic Clamp: hyperinsulinemic glucose clamp separated by 8 weeks</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="28"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Percent Changes in Endothelial Function as Measured by Flow Mediated Dilation by 2D Doppler Ultrasound</title>
            <description>A measure of the baseline arterial dilation is compared to the post intervention measure of dilation of the brachial artery.</description>
            <units>percentage of change</units>
            <param>Mean</param>
            <dispersion>Standard Error</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="7" spread="1"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Glucose Clamp</title>
          <description>Day 1 euglycemia, day 2 hypoglycemia
Hyperinsulinemic Hypoglycemic Clamp: hyperinsulinemic glucose clamp separated by 8 weeks</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Stephen N. Davis</name_or_title>
      <organization>University of Maryland, Baltimore</organization>
      <phone>410-328-2488</phone>
      <email>sdavis@medicine.umaryland.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
